Neurociencia del consumo y dependencia de sustancias psicoactivas
Neurociencia del consumo y dependencia de sustancias psicoactivas Neurociencia del consumo y dependencia de sustancias psicoactivas
6. TRASTORNOS CONCURRENTESPetty F (1995) GABA and mood disorders: a brief review and hypothesis.Journal of Affective Disorders, 34:275–281.Pomerleau O, Adkins D, Pertschuk M (1978) Predictors of outcome and recidivismin smoking cessation treatment. Addictive Behaviors, 3:65–70.Post RM y colab. (1982) Peptides in the cerebrospinal fluid of neuropsychiatricpatients: an approach to central nervous system peptide function. Life Sciences,31:1–15.Pristach CA, Smith CM (1996) Self-reported effects of alcohol use on symptomsof schizophrenia. Psychiatric Services, 47:421–423.Rajarethinam R y colab. (2001) Hippocampus and amygdala in schizophrenia:assessment of the relationship of neuroanatomy to psychopathology. PsychiatryResearch, 108:79–87.Razi K y colab. (1999) Reduction of the parahippocampal gyrus and the hippocampusin patients with chronic schizophrenia. British Journal of Psychiatry,174:512–519.Regier DA y colab. (1990) Comorbidity of mental disorders with alcohol andother drug abuse: results from the Epidemiological Catchment Area (ECA)Study. Journal of the American Medical Association, 264:2511–2518.Reid MS y colab. (2000) Nicotine stimulation of extracellular glutamate levels inthe nucleus accumbens: neuropharmacological characterization. Synapse,35:129–136.Richter RM, Weiss F (1999) In vivo CRF release in rat amygdala is increasedduring withdrawal after cocaine withdrawal in self-administering rats. Synapse,32:254–261.Richter RM y colab. (1995) Sensitization of cocaine-stimulated increase in extracellularlevels of corticotropin-releasing factor from the rat amygdala after repeatedadministration as determined by intracranial microdialysis. NeuroscienceLetters, 187:169–172.Robbins AS (1993) Pharmacological approaches to smoking cessation. AmericanJournal of Preventive Medicine, 9:31–33.Roberts AJ, Cole M, Koob GF (1996) Intra-amygdala muscimol decreases operantethanol self-administration in dependent rats. Alcoholism: Clinical andExperimental Research, 20:1289–1298.Robins LN y colab. (1984) Lifetime prevalence of specific psychiatric disordersin three sites. Archives of General Psychiatry, 41:949–958.Robins LN, Regier DA, eds (1991) Psychiatric disorders in America: theEpidemiologic Catchment Area Study. Nueva York, NY, EE.UU. The Free Press.Robinson D y colab. (1991) Mood responses of remitted schizophrenics tomethylphenidate infusion. Psychopharmacology, 105:247–252.Rosenthal RN, Hellerstein DJ, Miner CR (1994) Positive and negative syndrometypology in schizophrenic patients with psychoactive substance use disorders.Comprehensive Psychiatry, 35:91–98.Rossetti ZL, Hmaidan Y, Gessa GL (1992) Marked inhibition of mesolimbicdopamine release: a common feature of ethanol, morphine, cocaine and amphet-203
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASamine abstinence in rats. European Journal of Pharmacology, 221:227–234.Rounsaville BJ y colab. (1982) Heterogeneity of psychiatric disorders in treatedopiate addicts. Archives of General Psychiatry, 39:161–168.Rounsaville BJ y colab. (1987) Psychopathology as a predictor of treatment outcomein alcoholics. Archives of General Psychiatry, 44:505–513.Rounsaville BJ y colab. (1991) Psychiatric diagnoses of treatment-seekingcocaine abusers. Archives of General Psychiatry, 48:43–51.Rowley HL y colab. (2000) A comparison of the acute effects of zotepine andother antipsychotics on rat cortical dopamine release, in vivo. Naunyn-Schmiedebergs Archives of Pharmacology, 361:187–192.Roy A y colab. (1991) Depression among alcoholics: relationship to clinical andcerebrospinal fluid variables. Archives of General Psychiatry, 48:428–432.Rubinow DR (1986) Cerebrospinal fluid somatostatin and psychiatric illness.Biological Psychiatry, 21:341–365.Rupp A, Keith S (1993) The costs of schizophrenia. Psychiatric Clinics of NorthAm, 16:413–423.Sandyk R (1993) Cigarette smoking: effects on cognitive functions and druginducedparkinsonism in chronic schizophrenia. International Journal ofNeuroscience, 70:193–197.Sanfilipo M y colab. (1996) Amphetamine and negative symptoms of schizophrenia.Psychopharmacology, 123:211–214.Satel SL y colab. (1991) Clinical phenomenology and neurobiology of cocaineabstinence: a prospective inpatient study. American Journal of Psychiatry,148:1712–1716.Scheibel AB, Conrad AS (1993) Hippocampal dysgenesis in mutant mouse andschizophrenic man: is there a relationship? Schizophrenia Bulletin, 19:21–33.Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: areview of supporting evidence. American Journal of Psychiatry, 122:509–522.Schneier FR, Siris SG (1987) A review of psychoactive substance use and abusein schizophrenia: patterns of drug choice. Journal of Nervous and MentalDisorders, 175:641–652.Schuckit MA (1985) The clinical implications of primary diagnostic groupsamong alcoholics. Archives of General Psychiatry, 42:1043–1049.Schuckit MA (1994) Alcohol and depression: a clinical perspective. ActaPsychiatrica Scandinavica, 377:28–32.Schuckit MA y colab. (1997a) Comparison of induced and independent majordepressive disorders in 2,945 alcoholics. American Journal of Psychiatry,154:948–957.Schuckit MA y colab. (1997b) The life-time rates of three major mood disordersand four major anxiety disorders in alcoholics and controls. Addiction,92:1289–1304.Self DW (1998) Neural substrates of drug craving and relapse in drug addiction.Annals of Medicine, 30:379–389.204
- Page 174 and 175: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 176 and 177: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 178 and 179: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 180 and 181: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 182 and 183: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 184 and 185: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 186 and 187: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 188 and 189: 5. BASES GENÉTICAS DE LAS FARMACOD
- Page 190 and 191: Capítulo 6Trastornos ConcurrentesI
- Page 192 and 193: 6. TRASTORNOS CONCURRENTES3. El uso
- Page 194 and 195: 6. TRASTORNOS CONCURRENTESy Meador-
- Page 196 and 197: 6. TRASTORNOS CONCURRENTESprobablem
- Page 198 and 199: 6. TRASTORNOS CONCURRENTESde drogas
- Page 200 and 201: 6. TRASTORNOS CONCURRENTESy Turski,
- Page 202 and 203: 6. TRASTORNOS CONCURRENTESEl víncu
- Page 204 and 205: 6. TRASTORNOS CONCURRENTESAlcohol y
- Page 206 and 207: 6. TRASTORNOS CONCURRENTESSerotonin
- Page 208 and 209: 6. TRASTORNOS CONCURRENTESFunción
- Page 210 and 211: 6. TRASTORNOS CONCURRENTESRECUADRO
- Page 212 and 213: 6. TRASTORNOS CONCURRENTEStos psiqu
- Page 214 and 215: 6. TRASTORNOS CONCURRENTESCarol G y
- Page 216 and 217: 6. TRASTORNOS CONCURRENTESdepressio
- Page 218 and 219: 6. TRASTORNOS CONCURRENTESHall RG y
- Page 220 and 221: 6. TRASTORNOS CONCURRENTESKapur S,
- Page 222 and 223: 6. TRASTORNOS CONCURRENTESMansvelde
- Page 226 and 227: 6. TRASTORNOS CONCURRENTESSevy S y
- Page 228: 6. TRASTORNOS CONCURRENTESlesions o
- Page 231 and 232: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 233 and 234: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 235 and 236: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 237 and 238: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 239 and 240: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 241 and 242: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 243 and 244: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 245 and 246: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 247 and 248: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 249 and 250: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 251 and 252: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 253 and 254: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 255 and 256: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 257 and 258: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 259 and 260: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 261 and 262: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 263 and 264: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 265 and 266: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 267 and 268: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 269 and 270: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 272 and 273: Índice AnalíticoNota: los número
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASamine abstinence in rats. European Journal of Pharmacology, 221:227–234.Rounsaville BJ y colab. (1982) Heterogeneity of psychiatric disor<strong>de</strong>rs in treatedopiate addicts. Archives of General Psychiatry, 39:161–168.Rounsaville BJ y colab. (1987) Psychopathology as a predictor of treatment outcomein alcoholics. Archives of General Psychiatry, 44:505–513.Rounsaville BJ y colab. (1991) Psychiatric diagnoses of treatment-seekingcocaine abusers. Archives of General Psychiatry, 48:43–51.Rowley HL y colab. (2000) A comparison of the acute effects of zotepine andother antipsychotics on rat cortical dopamine release, in vivo. Naunyn-Schmie<strong>de</strong>bergs Archives of Pharmacology, 361:187–192.Roy A y colab. (1991) Depression among alcoholics: relationship to clinical andcerebrospinal fluid variables. Archives of General Psychiatry, 48:428–432.Rubinow DR (1986) Cerebrospinal fluid somatostatin and psychiatric illness.Biological Psychiatry, 21:341–365.Rupp A, Keith S (1993) The costs of schizophrenia. Psychiatric Clinics of NorthAm, 16:413–423.Sandyk R (1993) Cigarette smoking: effects on cognitive functions and druginducedparkinsonism in chronic schizophrenia. International Journal ofNeuroscience, 70:193–197.Sanfilipo M y colab. (1996) Amphetamine and negative symptoms of schizophrenia.Psychopharmacology, 123:211–214.Satel SL y colab. (1991) Clinical phenomenology and neurobiology of cocaineabstinence: a prospective inpatient study. American Journal of Psychiatry,148:1712–1716.Scheibel AB, Conrad AS (1993) Hippocampal dysgenesis in mutant mouse andschizophrenic man: is there a relationship? Schizophrenia Bulletin, 19:21–33.Schildkraut JJ (1965) The catecholamine hypothesis of affective disor<strong>de</strong>rs: areview of supporting evi<strong>de</strong>nce. American Journal of Psychiatry, 122:509–522.Schneier FR, Siris SG (1987) A review of psychoactive substance use and abusein schizophrenia: patterns of drug choice. Journal of Nervous and MentalDisor<strong>de</strong>rs, 175:641–652.Schuckit MA (1985) The clinical implications of primary diagnostic groupsamong alcoholics. Archives of General Psychiatry, 42:1043–1049.Schuckit MA (1994) Alcohol and <strong>de</strong>pression: a clinical perspective. ActaPsychiatrica Scandinavica, 377:28–32.Schuckit MA y colab. (1997a) Comparison of induced and in<strong>de</strong>pen<strong>de</strong>nt major<strong>de</strong>pressive disor<strong>de</strong>rs in 2,945 alcoholics. American Journal of Psychiatry,154:948–957.Schuckit MA y colab. (1997b) The life-time rates of three major mood disor<strong>de</strong>rsand four major anxiety disor<strong>de</strong>rs in alcoholics and controls. Addiction,92:1289–1304.Self DW (1998) Neural substrates of drug craving and relapse in drug addiction.Annals of Medicine, 30:379–389.204
Change language